Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 04-2015 | 03-2015 | 01-2015 | 12-2014 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,814 | N/A | -20,722 | -20,720 |
| Depreciation Amortization | 17 | 50 | 54 | 50 |
| Accounts receivable | 1,091 | N/A | -3,601 | N/A |
| Accounts payable and accrued liabilities | -1,556 | N/A | 3,056 | N/A |
| Other Working Capital | -465 | -540 | -545 | -540 |
| Other Operating Activity | 803 | 0 | 3,221 | 2,680 |
| Operating Cash Flow | $-5,924 | $-490 | $-18,537 | $-18,530 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -26 | -50 | -57 | -50 |
| Other Investing Activity | 11 | 0 | 84 | 70 |
| Investing Cash Flow | $-15 | $-50 | $26 | $20 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 40,029 | N/A | 36,052 | N/A |
| Other Financing Activity | -6,272 | 36,050 | -2,426 | 33,620 |
| Financing Cash Flow | $33,757 | $36,050 | $33,626 | $33,620 |
| Beginning Cash Position | 17,268 | N/A | 3,323 | 3,320 |
| End Cash Position | 45,086 | N/A | 18,439 | 18,430 |
| Net Cash Flow | $27,818 | $35,510 | $15,116 | $15,110 |
| Free Cash Flow | ||||
| Operating Cash Flow | -5,924 | -490 | -18,537 | -18,530 |
| Capital Expenditure | -26 | N/A | -57 | N/A |
| Free Cash Flow | -5,950 | -490 | -18,594 | -18,530 |